0

ALVESCO از شرکت COVIS

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

ALVESCO از شرکت COVIS

New Drug Application (NDA): 021658

Company: COVIS

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ALVESCO CICLESONIDE 0.08MG/INH AEROSOL, METERED;INHALATION Prescription

None

Yes Yes
ALVESCO CICLESONIDE 0.16MG/INH AEROSOL, METERED;INHALATION Prescription

None

Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
01/10/2008 ORIG-1 Approval

Type 3 – New Dosage Form

STANDARD

Label (PDF)

Letter (PDF)

Review

Summary Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021658lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021658s000ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/021658s000TOC.cfm
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/021658s000_SumR.pdf

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
04/22/2014 SUPPL-8 Manufacturing (CMC)

Label is not available on this site.

10/07/2013 SUPPL-7 Manufacturing (CMC)

Label is not available on this site.

12/17/2012 SUPPL-6 Efficacy-Labeling Change With Clinical Data

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021658s006lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021658Orig1s006ltr.pdf

11/19/2012 SUPPL-5 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021658s005lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021658Orig1s005ltr.pdf

12/22/2008 SUPPL-2 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021658s002lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021658s002ltr.pdf

10/10/2008 SUPPL-1 Labeling-Container/Carton Labels

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
12/17/2012 SUPPL-6

Efficacy-Labeling Change With Clinical Data

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021658s006lbl.pdf
11/19/2012 SUPPL-5

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021658s005lbl.pdf
12/22/2008 SUPPL-2

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021658s002lbl.pdf
01/10/2008 ORIG-1 Approval

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021658lbl.pdf
بخوانید  CABAZITAXEL از شرکت APOTEX INC
برچسب‌ها:

نظرات کاربران